No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

WMC Anchor Joe Birch named St. Jude Hero

Editor: What To Know

  • The lifelong Memphian is a familiar face to many in the MidSouth as the longtime news anchor at WMC News Channel 5 in Memphis, where he has been supporting the lifesaving mission of St.
  • Jude Heroes® running a virtual race in their hometowns in 2019 to patient families whose bravery and tenacity continue to inspire and supporters in Memphis who won’t stop until no child dies from cancer.
  • Television news anchor Joe Birch made a commitment to himself and his community 20 years ago – to lace up, run and support the kids of St.

Television news anchor Joe Birch made a commitment to himself and his community 20 years ago – to lace up, run and support the kids of St. Jude Children’s Research Hospital ® while fundraising as a St. Jude Hero ®.

That promise became a 20-year commitment and because of his dedication to Memphis and supporting St. Jude kids, Birch has been named the 2021 St. Jude Hero Among Us.

The Hero Among Us award is given each year during St. Jude Memphis Marathon® Weekend presented by Juice Plus+® to a St. Jude Hero who exemplifies what it means to participate with purpose for the kids of St. Jude, going the extra mile to ensure families never receive a bill from St. Jude, not for treatment, travel, housing or food. St. Jude Heroes are athletes who fundraise while training to support the lifesaving mission of St. Jude: Finding cures. Saving children. ®

The lifelong Memphian is a familiar face to many in the MidSouth as the longtime news anchor at WMC News Channel 5 in Memphis, where he has been supporting the lifesaving mission of St. Jude Children’s Research Hospital each December during St. Jude Memphis Marathon Weekend.

Birch was among the 2,900 participants at the first St. Jude Memphis Marathon Weekend in 2002 and is one of just a handful of people who have participated every year since. In addition, Birch has brought St. Jude into the homes of millions by telling the stories of dedicated St. Jude Heroes® running a virtual race in their hometowns in 2019 to patient families whose bravery and tenacity continue to inspire and supporters in Memphis who won’t stop until no child dies from cancer. More than 30 runners have participated in all 20 years of this event. Some of their personal stories are featured on St. Jude Inspire.

Joe Birch has been a tireless hometown champion of St. Jude Children’s Research Hospital for more than two decades and he continues to further its lifesaving mission through his commitment to our cause,” said Richard C. Shadyac Jr., President and CEO of ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital. “His efforts may be focused locally in our beloved Memphis, but his impact is global. Support from St Jude Heroes like Joe allows St. Jude to embark on its six-year, $11.5 billion strategic plan to impact the more than 400,000 kids afflicted with cancer around the world each year. On this 20th anniversary of the St. Jude Memphis Marathon Weekend, I honor all St. Jude Heroes and I am grateful for Joe, our St. Jude Hero Among Us, a loyal friend to our community who will always be part of our St. Jude family.”

This is not the first time Birch has been recognized for his philanthropic efforts. He received the Legacy Award in 2016 from ALSAC, the fundraising and awareness organization for St. Jude, for running 15 years as a St. Jude Hero. In his 20 years supporting St. Jude, he has rallied his supporters to raise tens of thousands of dollars for the kids of St. Jude. Among many other honors, Birch was the 2004 recipient of the Frank Horton Award, given annually by the Memphis Runners Track Club to recognize exceptional volunteerism by a person.

Since 2002, when 2,900 marathon and half marathoners took to the streets of Memphis for the first-ever St. Jude Memphis Marathon Weekend, tens of thousands of participants have united for what has become the largest single-day fundraiser for St. Jude, a marquee event that not only brings families, friends, neighborhood associations, and businesses together for a purpose, but also creates global awareness around the important work that happens every day at St. Jude.

Childhood cancer is a multi-trillion-dollar, multi-year problem. Fundraising campaigns like  St. Jude Memphis Marathon Weekend and the fans who support it fuel the overarching $11.5 billion, six-year St. Jude strategic plan, which includes tripling its global investment to impact the more than 400,000 kids with cancer around the world each year.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy